BioScrip
IR Contacts | Financial Tear Sheet | E-mail Alerts
Corporate Profile

BioScrip, Inc. is a leading national provider of infusion and home care management solutions. BioScrip partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves. BioScrip provides its infusion and home care services from over 70 locations across 28 states.

BioScrip also offers complete Pharmacy Benefit Management programs that include customized benefit plan design, pharmacy network management and sophisticated reporting capabilities that deliver improved clinical and economic outcomes.

Stock Quote
BIOS (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$2.68
Change (%) Stock is Up 0.06 (2.29%)
Volume1,546,676
Data as of 06/23/17 4:00 p.m. ET
Refresh quote
Presentations
DateTitle
03/27/17
Download DocumentationInvestor Meetings March 2017 Presentation
Events
There are currently no webcasts scheduled at his time.
There are currently no events scheduled.
More Events >>
Press Releases
DateTitlePrint
05/30/17BioScrip Provides Update on UnitedHealthcare ContractPrinter Friendly Version
05/24/17BioScrip to Present at the Jefferies 2017 Global Healthcare ConferencePrinter Friendly Version
05/04/17BioScrip Reports First Quarter 2017 Financial ResultsPrinter Friendly Version
More Press Releases >>
SEC filings
Filing DateFormDescription
06/07/17SC 13GA statement of beneficial ownership of common stock by certain persons
05/04/174Statement of changes in beneficial ownership of securities
05/04/174Statement of changes in beneficial ownership of securities
05/04/174Statement of changes in beneficial ownership of securities
More SEC Filings >>
Proxy Materials
Title
Download Documentation Proxy Supplement
Download Documentation Proxy Statement
Download Documentation 2014 Annual Report on Form 10-K
Get help downloading or viewing the above file types
BioScrip Corporate Offices

1600 Broadway, Suite 700
Denver, CO 80202
Phone: (720) 697-5200


Primary IR Contact
Steve Deitsch
BioScrip, Inc.
Phone: (720) 697-5150
E-mail: stephen.deitsch@bioscrip.com

Transfer Agent
American Stock Transfer & Trust Co.
59 Maiden Lane
New York, NY 10038
Phone: (718) 921-8124

Accountants
KPMG LLP
1225 17th Street
Suite 800
Denver, CO 80202
Phone: (303) 296-2323

Data provided by Nasdaq. Minimum 15 minutes delayed.
^ Back to Top